Butoconazole Production Cost Reports

The report provides a detailed analysis essential for establishing a butoconazole production plant. It encompasses all critical aspects necessary for butoconazole production, including the cost of butoconazole production, butoconazole plant cost, butoconazole production costs, and the overall butoconazole production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating a butoconazole production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.

Butoconazole is a synthetic antifungal compound mainly used in the treatment of vaginal yeast infections caused by Candida species. It is primarily used in the treatment of fungal infections, especially vaginal yeast infections caused by Candida species, particularly Candida albicans. It works by stopping the growth of fungi and helping to relieve symptoms such as itching, irritation, and discharge. It is commonly formulated into creams and suppositories for local application. The compound exhibits broad-spectrum fungistatic activity against pathogenic yeasts, dermatophytes, moulds, and dimorphic fungi. It is widely used in gynaecological medicines for the treatment of vulvovaginal candidiasis, especially in non-pregnant women, due to its effectiveness and targeted action. It is often preferred for its single-dose treatment, which increases convenience and improves patient compliance. In addition, it is also utilised in pharmaceutical research for developing improved antifungal therapies and studying fungal resistance.

The demand for butoconazole is driven by its application as a vaginal antifungal agent in gynaecological care for treating fungal infections, which supports its market expansion. Its application as a vaginal cream for the local treatment of vulvovaginal candidiasis caused by Candida species significantly promotes its demand in gynaecology and healthcare sectors. Its usage as an antifungal medication for short-term therapy to relieve symptoms associated with fungal infections, like itching, burning, and discharge, also boosts its demand in the pharmaceutical industry. Its involvement as an important antifungal agent in research studies associated with the development of potent antifungal drug formulations for various fungal infections also drives its market growth. Additionally, industrial butoconazole procurement depends on factors such as the cost and availability of pharmaceutical-grade raw materials, adherence to drug safety regulations, and evolving quality standards. Furthermore, ongoing developments in formulation technologies, supplier consistency, environmental compliance, and reliable distribution networks play a crucial role in influencing global procurement practices for butoconazole.

Raw Material for Butoconazole Production

According to the butoconazole production plant project report, the major raw materials for butoconazole production include 4-chlorobenzylmagnesium bromide, epichlorohydrin, imidazole, thionyl chloride, and 2,6-dichlorothiophenol.

Production Process of Butoconazole

The extensive butoconazole production cost report consists of the following industrial production process:

1. Production via Chemical Synthesis: The production process of butoconazole begins with the preparation of a chlorophenyl-substituted butanol intermediate by reacting 4-chlorobenzylmagnesium bromide with epichlorohydrin. Then, this intermediate is treated with imidazole in the presence of a base to introduce the imidazole ring, which forms an imidazolyl butanol compound. The hydroxyl group in this intermediate is further replaced with a chlorine atom using thionyl chloride to form a reactive chloroalkyl intermediate. Finally, this chlorinated compound is reacted with 2,6-dichlorothiophenol to give butoconazole as the final product.

Butoconazole is an imidazole antifungal agent that appears as a white to off-white solid. The molecular formula of the compound is C19H17Cl3N2S, and its molar mass is 411.78 g/mol. It has a density of approximately 1.32 g/cm³, and its melting point is 68–70.5 °C. The boiling point of the compound is approximately 566.9 °C, and its flash point is 296.7 °C. It is practically insoluble in water but is soluble in dimethyl sulfoxide (DMSO). Common side effects associated with its use include local irritations such as vulvar or vaginal burning, itching, soreness, and swelling. It is recommended to use this compound strictly as directed by a healthcare professional, and it should be kept away from the eyes and mucous membranes during application.